29-Jul-2022 | Facts and Factors
According to Facts and Factors, the global Cardiac POC Testing Devices market size was worth USD 1,319.4 million in 2021 and is estimated to grow to USD 1819.25 million by 2028, with a compound annual growth rate (CAGR) of approximately 5.50% over the forecast period. The report analyzes the Cardiac POC Testing Devices market’s drivers, restraints/challenges, and their effect on the demands during the projection period. In addition, the report explores emerging opportunities in the Cardiac POC Testing Devices market.
POC (point of care) devices are mostly used for medical diagnostic tests. These tests are performed at a convenient time and location for patient care. Cardiac POC testing is a diagnostic procedure for the heart that is performed at the patient's point of care or very close by. In addition, POC testing is a blood diagnostic procedure used to find cholesterol and blood clotting issues. Cardiac POCT considerably reduces the time needed to retrieve reports and data. These cardiac POC devices help patients save significant time by shipping medical samples to labs and waiting for long periods for findings. Owing to the rise in demand for Cardiac POC Testing Devices, the global Cardiac POC Testing Devices market is estimated to grow at a CAGR of 5.50% during the forecast period.
Browse the full “ Cardiac POC Testing Devices Market Size, Share, Growth Analysis Report By Product Type (Cardiac Markers Test and Analyzers), By End User (Research Laboratories, Hospitals, Ambulatory Surgical Centers, Diagnostic Laboratories and Others), and By Region- Global and Regional Industry Insights, Overview, Comprehensive Analysis, Trends, Statistical Research, Market Intelligence, Historical Data and Forecast 2022 – 2028" report at https://www.fnfresearch.com/cardiac-poc-testing-devices-market
Rising government spending on the construction of healthcare infrastructure to enable advanced healthcare facilities is a crucial factor accelerating market growth. Other important factors driving the cardiac point of care testing market include growing numbers of cardiac patients, changing lifestyle patterns, an increase in infectious diseases, and rapid economic growth in emerging economies. In addition, the cardiac point-of-care testing kits market will see new growth potential during the anticipated period due to the rising technology developments and modernization in the healthcare industry. However, strict government regulations concerning product approval, rising costs for point-of-care testing equipment, product recalls, and industry resistance to changing the status quo are the main factors, among others, that will restrain market growth and pose additional challenges to the development of the cardiac point-of-care testing kits market over the course of the forecast period.
Segmental Overview
The Global Cardiac POC Testing DevicesMarket is segregated based on product type, end-user, and region. Based on product type, the market is divided into Cardiac Markers Test and Analyzers. Among these, the Analyzerssegment dominated the market in 2021. Based on end-user, the market is divided into Research Laboratories, Hospitals, Ambulatory Surgical Centers, Diagnostic Laboratories and Others. Over the forecast period, the Hospitals segment is expected to develop at the fastest rate in 2021.
Regional Overview
North America is expected to dominate the Global Cardiac POC Testing DevicesMarket in 2021. The highly developed healthcare infrastructure, incredibly favorable reimbursement standards, and the existence of a number of key industry players all contribute to the rapid rise of the North American regional market. However, over the forecast period, the Asia Pacific regional market is expected to grow at a significant rate in 2021. The Asia Pacific region is also steadily growing due to increased awareness of cardiac diagnosis and treatment and rising healthcare expenditure. In addition, expansion in government investments in the construction of healthcare infrastructure and the launch of novel products by leading market participants are also driving the market growth.
Report Scope
Report Attribute |
Details |
Market Size in 2021 |
USD 1,319.4 Million |
Projected Market Size in 2028 |
USD 1,819.25 Million |
CAGR Growth Rate |
5.50% CAGR |
Base Year |
2021 |
Forecast Years |
2022-2028 |
Key Market Players |
Abbott Laboratories, Roche Diagnostics, Nexus -Dx, Lifesign LLC BG Medicine Inc., Siemens Healthneers, Medtronic Inc., and Others |
Key Segment |
By Product Type, End User, and Region |
Major Regions Covered |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
Purchase Options |
Request customized purchase options to meet your research needs. Explore purchase options |
Key Players Insights
Key players functioning in the global Cardiac POC Testing Devices market include Abbott Laboratories, Roche Diagnostics, Nexus -Dx, Lifesign LLC BG Medicine Inc., Siemens Healthneers and Medtronic Inc.
Recent developments:
- In April 2021, Roche disclosed five new intended uses for two essential cardiac biomarkers based on Elecsys technology: high sensitive cardiac troponin T (cTnT-hs) and N-terminal pro-brain natriuretic peptide test (NT-proBNP). These clinical biomarkers aid in the diagnosis of heart attacks and the effective management of heart failure.
- In May 2019, Medtronic, a market leader in the global cardiac POC testing equipment market, announced the launch of the TelescopeTM Guide Extension Catheter. This newly created catheter will be used to provide more access and support to the distal lesions. In addition, these extension catheters will aid in delivering coronary balloons, stents, and other types of interventional devices during the angioplasty process, restoring blood flow through the peripheral and coronary arteries.
The Global Cardiac POC Testing Devices market is segmented as follows:
By Product Type
- Cardiac Markers Test
- Analyzers
By End User
- Research Laboratories
- Hospitals
- Ambulatory Surgical Centers
- Diagnostic Laboratories
- Others
By Region
- North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Nordic Countries
- Benelux Union
- Belgium
- The Netherlands
- Luxembourg
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Southeast Asia
- Indonesia
- Thailand
- Malaysia
- Singapore
- Rest of Southeast Asia
- Rest of Asia Pacific
- The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Contact Us:
Facts & Factors
A 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com
